期刊文献+

宫颈癌患者外周血T淋巴细胞亚群及血VEGF水平的临床意义 被引量:1

Clinical Significance of Peripheral Blood T Lymphocyte Subsets and Blood Levels of VEGF in Patients with Cervical Cancer
下载PDF
导出
摘要 目的探讨宫颈癌患者外周血T淋巴细胞亚群及血VEGF水平的临床意义。方法采用流式细胞仪(FCM)对34例宫颈癌患者外周血T淋巴细胞亚群进行检测,同时应用ELISA法检测血VEGF水平。随机抽取健康女性20例为对照组,比较两组T淋巴细胞亚群及VEGF。结果宫颈癌患者外周血CD4+、CD4+/CD8+比值较对照组均明显下降(P<0.05),而CD8+水平、IL-6、VEGF显著升高。IFN-γ水平与对照组无明显差异性。肿瘤期别越晚,CD4+/CD8+比值越低,CD8+、IL-6、VEGF水平越高,IFN-γ水平则无明显差异性。结论宫颈癌患者T淋巴细胞亚群改变导致细胞免疫功能降低,肿瘤细胞发生免疫逃逸,促进宫颈癌的发生、发展;VEGF诱导肿瘤血管形成,促进宫颈癌的侵袭、转移。 Objective To study the clinical significance of T-cells subgroup and vascular endothlial growth factor level in patients with cervical cancer.Methods The levels of T-cells subgroup and vascular endothelial growth factor(VEGF) were investigated in 34 patients with cervical cancer by flow cytometry(FCM) and enzyme-linked immunosorbent assay(ELISA).20 healthy women were selected randomly as the control group.Results In group of cervical cancer,the blood CD4+ level and the ratio of CD4+/CD8+ were obviously lower than that of control group,but the levels of CD8+、IL-6、VEGF were significantly higher than in control group,which changed with cervical cancer classification.There was no significantly difference of the IFN-γ level between two groups.Conclusion The change of T-cells subgroup level in patients with cervical cancer may lead to a decreased cytoimmunity functions,the tumor immune escape caused the tumorigenesis and enhanced the progression of cancer;on the other hand,VEGF induced the angiogenesis of cancer,which promoted the metastasis of cervical cancer.
出处 《中国医药指南》 2012年第34期47-49,共3页 Guide of China Medicine
关键词 宫颈癌 T淋巴细胞亚群 VEGF Cervical cancer T Lymphocyte Subsets VEGF
  • 相关文献

参考文献13

  • 1Yang XH,Yangiva S,lchida T,et al.Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatoeellular earcinoma[J].J Hepatol,2006,45(2):254-262.
  • 2Azab NA,Bassyouni IH,Emad Y, et al.CD4+ CD25+ regulatory T-cells(TREG) in SystemicLuptus Erythematosus(SLE) patients: The possible influence of treatment with corticosteroids[J].Clini Immunol,2008,127(2):151-157.
  • 3Roy H,Bhardwaj S,Yla-Herttuala S. Biology of vascular endothelial growth factors[J]. FEBS Lett,2006,580(12):2879-2887.
  • 4Franco EL,Schlecht NF, Saslow D.The epidemiology of cervical cancer[J].Cancer J,2003,9(5):348-359.
  • 5Holm H,Pilch H,Gunzel S,et al.CD4+ tumour -infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papilonavirus-E7 [J].J Immunol,1999,163(10):571-5722.
  • 6孙林,温江涛,周彦.宫颈癌患者外周血T淋巴细胞及NK细胞的检测及其临床意义[J].标记免疫分析与临床,2009,16(4):224-226. 被引量:21
  • 7Nedergaard BS,LadekarlM,Nyengaard JR,et al.A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma.Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years[J].Gynecol Oncol,2008,108(1):106.
  • 8Aniszewski JP,Valyasevi RW, Bahn RS.Relationship between duration and predominant orbital T cell subset in Graves' opthamopathy[J].Clin Endocinol Metab,2000,85(2):776-780.
  • 9Matera P, Rozados VR,Gervasoni SI,et al.Th2/Thl swich induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model[J].Cancer Immumol Immunother,2002,11(50):588-596.
  • 10姚金晶,陈宜涛.Thl/Th2平衡调节与疾病发生的研究进展[J].现代生物医学研究进展,2009,9(13):2597-2600.

二级参考文献11

  • 1Nakano Y, Kobayashi W, Sugai S, et al. Expression of tumor necrosis factor - alpha and interleukin - 6 in oral squamous cell carcinoma[J]. Jpn J Cancer Res, 1999,90 (8) :858 - 866.
  • 2Iglesias M, Plowman GD, Woodworth CD, et al. Interleukin - 6 and interleukin - 6 soluble receptor regulate proliferation of normal, human papillomavirus - immortalized, and carcinoma - derived cervical cells in vitro[J]. Am J Pathol,1995,146(4) :944 -952.
  • 3Castrilli G,Tatone D, Diodoro MG,et al. Interleukin 1 alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells [ J ]. Br J Cancer, 1997,75 ( 6 ) : 855 - 859.
  • 4Cohen T, Nahari D, Cerem IW, et al. Interleukin -6 induces the expression of vascular endothelial growth factor[J].J Biol Chem, 1996,271:736 - 741.
  • 5Wei LH, Kuo ML, Chen CA, et al. Interleukin - 6 promotes cervical tumor growth by VEGF - dependent angiogenesis via a STAT3 pathway[J]. Oncogene,2003,22(10) : 1517 - 1527.
  • 6Niu G,Wright KL,Huang M,et al. Constitutive Stat3 activity up - regulates VEGF expression and tumor angiogenesis[ J]. Oncogene, 2002,21 (13) :2000 -2008.
  • 7Lissni P, Brivio F, Ferranle R, et al. Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer [J]. Int J Biol Markets, 2000,15 (1) : 22-25.
  • 8Decensi A, Costa A. Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer [J]. Eur J Cancer, 2000, 36 (6) : 694-709.
  • 9Kuss I, Hathway B, Ferris R L, et al. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck [J]. Clin Cancer Res, 2004, 10 ( 11 ) : 3755-3762.
  • 10汤钊酋.现代肿瘤学[M].上海:卜海医科大学出版社,1993:129-132.

共引文献22

同被引文献30

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部